-
EF Sustainable Debt Awards 2024 nominations open
09 January 2024Nominations have opened for the 2024 Environmental Finance Sustainable Debt Awards, formerly known as the Environmental Finance Bond Awards.
-
Mirova bullish about European renewables as it trumpets wind exit
09 January 2024Mirova said it continues to see opportunities in the European renewables market despite the macroeconomic outlook, as it exited a wind project investment that saw its valuation boosted by higher energy prices.
-
NZBA to publish accountability mechanism in 'coming weeks'
08 January 2024The Net Zero Banking Alliance (NZBA) will in "coming weeks" publish details of its procedure for engaging with members not meeting their commitments, ahead of a deadline for the founding members of UN-convened alliance to report their targets.
-
UK government urged to strengthen biodiversity credit legislation
08 January 2024The UK government has been urged by WWF to strengthen its mandatory biodiversity credit legislation, amid warnings that a lack of regulation creates is "fertile ground" for poor quality credits.
-
ESG fund flows outperform broader market in 'resilient' 2023
08 January 2024The flows into environmental, social and governance (ESG)-focused funds "outstripped" the broader market in 2023 despite overall inflow totals remaining lower than recent records, according to Barclays research.
-
Regulators open consultation on free EU database
08 January 2024 -
COP28: What can we take away?
08 January 2024The agreement has increased transition risks, writes Anya Solovieva
-
Corporate sustainable bond issuance 'slump' to reverse in 2024, says Barclays
05 January 2024Corporate sustainable bond issuance in 2024 is forecast to reverse following a two-year "slump" as US dollar supply returns to growth following a sharp decline in 2023, according to Barclays.
-
Bridges exits AgilityEco, making x3 return
05 January 2024 -
M&G Investments backs bio-pesticide business to tune of €75m
05 January 2024M&G Investments has put €75m into biological pest and disease control business Biobest via its Catalyst strategy.